Volatile Organic Compounds: A Proinflammatory Activator in Autoimmune Diseases
July 2022
in “
Frontiers in Immunology
”
Studysummary This review discusses the potential impact of volatile organic compound exposure on the onset and progression of autoimmune diseases and reports no new experimental findings.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on frontiersin.org →